New Nordic Limited
Registered name: NEW NORDIC LIMITED
New Nordic Limited made £7.4m revenue and £125k profit in the year to 31 Dec 2025.
New Nordic Limited’s revenue grew 63% to £7.4m in the year to 31 Dec 2025, with £125k profit and 5 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Lyndhurst; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Lyndhurst, South East
- Age
- 30 yrs · since 1995
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “New Nordic Healthbrands AB”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £4.5m | £7.4m |
| Cost of sales | £2.7m | £5.2m |
| Gross profit | £1.8m | £2.2m |
| Operating profit | £133k | £167k |
| Profit before tax | £133k | £167k |
| Profit after tax | £99.7k | £125k |
| Profit (best available) | £99.7k | £125k |
| Staff costs | £177k | £351k |
| Employees (average) | 3 | 5 |
| Ratios | ||
| Profit margin | 2.2% | 1.7% |
| Gross margin | 40.6% | 30.3% |
| Revenue per employee | £1.5m | £1.5m |
| Profit per employee | £33.2k | £25k |
| Growth (year on year) | ||
| Revenue growth | — | ▲62.7% |
| Profit growth | — | ▲25.6% |
| Headcount growth | — | ▲66.7% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £51.5k | £55k |
| Net assets | £1.3m | £1.2m |
| Current assets | £1.5m | £2.5m |
| Debtors | £812k | £1.6m |
| Source | FullAccounts · bulk data Feb 2026 | FullAccounts · bulk data Feb 2026 |
How the business works
- Profit margin
- 1.7%
- Profit ÷ revenue.
- Gross margin
- 30.3%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £1.5m
- Revenue ÷ average employees.
- Profit per employee
- £25k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 21.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼6%
- Now £1.2m
- Cash at bank
- ▲7%
- Now £55k
- Headcount
- ▲67%
- Now 5
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Ascot Laboratories LimitedBorehamwood · Manufacture of basic pharmaceutical products
- Revenue
- £8.9m
- Profit
- £645k
- Staff
- 66
- Vector Consumer LimitedPrenton · Manufacture of basic pharmaceutical products
- Revenue
- £10.6m
- Profit
- £33.1k
- Staff
- 14
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
- Cosmarida LimitedSheffield · Manufacture of basic pharmaceutical products
- Revenue
- £11.1m
- Profit
- £286k
- Staff
- 90
- Envigo RMS (UK) LimitedLoughborough · Manufacture of basic pharmaceutical products
- Revenue
- £11.4m
- Profit
- £209k
- Staff
- 145
- Manx Healthcare LimitedWarwick · Manufacture of basic pharmaceutical products
- Revenue
- £12.6m
- Profit
- £5.6m
- Staff
- 31
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £125k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.